What Do We Know About Scleroderma Now?

Recent Posts

• Antibodies vary by race, but don’t explain differences in scleroderma
• Profervia granted FDA orphan drug status as treatment for SSc
• Blood TSLP protein linked to greater risk of digital ulcers in SSc: Study
• Letairis may prevent PAH linked to scleroderma: Study
• IVIG effective in easing range of scleroderma symptoms: Review
• Radiation therapy may be used with caution in scleroderma: Study
• SSc lung cells show gene activity linked to scarring in study
• Certa’s FT011 granted orphan drug status in Europe for SSc
• Stem cell transplant normalizes scleroderma gene activity: Study
• Promoting cell death process may help to limit skin fibrosis in SSc